Verastem, Inc.

LSE:0LOV Stock Report

Market Cap: US$186.5m

Verastem Management

Management criteria checks 1/4

Verastem's CEO is Dan Paterson, appointed in Jun 2019, has a tenure of 5.5 years. total yearly compensation is $3.63M, comprised of 15% salary and 85% bonuses, including company stock and options. directly owns 0.094% of the company’s shares, worth $175.00K. The average tenure of the management team and the board of directors is 1.7 years and 3.3 years respectively.

Key information

Dan Paterson

Chief executive officer

US$3.6m

Total compensation

CEO salary percentage15.0%
CEO tenure5.5yrs
CEO ownership0.09%
Management average tenure1.7yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dan Paterson's remuneration changed compared to Verastem's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$93m

Jun 30 2024n/an/a

-US$89m

Mar 31 2024n/an/a

-US$106m

Dec 31 2023US$4mUS$545k

-US$87m

Sep 30 2023n/an/a

-US$77m

Jun 30 2023n/an/a

-US$75m

Mar 31 2023n/an/a

-US$73m

Dec 31 2022US$698kUS$470k

-US$74m

Sep 30 2022n/an/a

-US$73m

Jun 30 2022n/an/a

-US$78m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$2mUS$460k

-US$71m

Sep 30 2021n/an/a

-US$75m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$45m

Dec 31 2020US$2mUS$467k

-US$68m

Sep 30 2020n/an/a

-US$87m

Jun 30 2020n/an/a

-US$130m

Mar 31 2020n/an/a

-US$149m

Dec 31 2019US$2mUS$445k

-US$149m

Compensation vs Market: Dan's total compensation ($USD3.63M) is above average for companies of similar size in the UK market ($USD722.49K).

Compensation vs Earnings: Dan's compensation has increased whilst the company is unprofitable.

CEO

Dan Paterson (63 yo)

5.5yrs

Tenure

US$3,626,857

Compensation

Mr. Daniel W. Paterson, also known as Dan, serves as Chief Executive Officer Verastem, Inc. since August 1, 2023 and is its President of Verastem, Inc. since June 2019. He is Director of Verastem, Inc. sin...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Paterson
President5.5yrsUS$3.63m0.094%
$ 175.0k
Daniel Calkins
CFO and Principal Accounting & Financial Officer2.2yrsUS$622.56k0.015%
$ 28.3k
Richard Aldrich
Founder and Consultant10.3yrsUS$114.77kno data
Robert Weinberg
Co-Founder & Chair of Scientific Advisory Boardno datano datano data
Piyush Gupta
Co-Founderno datano datano data
Michelle Dipp
Co-Founderno datano datano data
Jonathan Pachter
Chief Scientific Officer8.7yrsUS$319.51kno data
Cathy Carew
Chief Organizational Effectiveness Officerno datano datano data
Nate Sanburn
Chief Business Officerless than a yearno datano data
Michael Crowther
Chief Commercial & Strategy Officer1.2yrsno datano data
Colleen Mockbee
Global Head of Regulatory Affairs & Developmentless than a yearno datano data
John Hayslip
Chief Medical Officerless than a yearno datano data

1.7yrs

Average Tenure

55.5yo

Average Age

Experienced Management: 0LOV's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Daniel Paterson
President1.4yrsUS$3.63m0.094%
$ 175.0k
Robert Weinberg
Co-Founder & Chair of Scientific Advisory Boardno datano datano data
Mario Sznol
Member of Scientific Advisory Boardno datano datano data
Michael Kauffman
Lead Independent Director12.1yrsUS$124.29k0.0012%
$ 2.3k
Paul A. Bunn
Independent Director3.5yrsUS$74.29k0%
$ 0
Eric Rowinsky
Independent Director7.6yrsUS$89.29k0%
$ 0
John Johnson
Independent Director4.7yrsUS$81.29k0%
$ 0
Robert Gagnon
Director2yrsUS$64.29k0.056%
$ 105.2k
Channing Der
Member of Scientific Advisory Board2.8yrsno datano data
Brian Stuglik
Director7.3yrsUS$2.30m0.22%
$ 402.7k
Anil Kapur
Independent Director2.2yrsUS$81.75k0%
$ 0
Michelle Robertson
Independent Director3.1yrsUS$84.29k0%
$ 0

3.3yrs

Average Tenure

65yo

Average Age

Experienced Board: 0LOV's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:34
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Verastem, Inc. is covered by 27 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Matthew CrossAlliance Global Partners
Kalpit PatelB. Riley Securities, Inc.